#United States #New York #Class Action #Levi Korsinsky #Ardent Health

Important Update for Ardent Health, Inc. Investors

Investors in Ardent Health, Inc. (traded under the ticker NYSE: ARDT) are being cautioned by Levi & Korsinsky, LLP about an ongoing class action lawsuit. This legal action addresses significant allegations of securities fraud and may have major ramifications for affected investors.

Overview of the Class Action

The class action complaint aims to recover losses on behalf of those who invested in Ardent Health, and it focuses on the period from July 18, 2024, to November 12, 2025. It contends that during this time, the company misrepresented its financial health by making misleading statements regarding its accounts receivable. The lawsuit argues that Ardent Health falsely claimed that they conducted comprehensive reviews of historical collections to determine the collectability of their accounts receivable, which, according to the claims, was not true.

Instead, the lawsuit states that the company utilized a simplified method that allowed them to report inflated levels of accounts receivable. This misrepresentation prevented the proper acknowledgment of losses due to uncollectible accounts, ultimately painting a false picture of the company’s financial stability.

Key Allegations

1. False Statements: The complaint particularly highlights that Ardent Health did not rely on detailed reviews for determining the collectability of their receivables, leading to an artificially inflated perception of their financial status.
2. Lack of Insurance Coverage: The complaint also mentions that Ardent Health did not maintain adequate professional liability insurance to cover potential claims, exposing investors to further risk.
3. Insufficient Reserves: The reserves maintained by Ardent Health were, according to the lawsuit, inadequate to manage the increasing pressure from medical malpractice claims, which poses additional risks to its financial standing.

What's Next?

Ardent Health investors have until March 9, 2026, to act if they wish to be considered for appointment as lead plaintiffs in the case. Importantly, participation in the case does not require investors to serve as lead plaintiffs, and they can secure their right to share in any financial recovery that may arise from the lawsuit without incurring any out-of-pocket costs.

Why Choose Levi & Korsinsky?

For over two decades, Levi & Korsinsky has established a reputation for securing substantial recoveries for shareholders and has consistently ranked among the top firms in the United States for securities litigation. Their team combines extensive experience with a dedicated workforce committed to representing investor interests in complex cases. With more than 70 employees, the firm is well-equipped to handle high-stakes legal challenges effectively.

Contact Information

If you are an investor in Ardent Health and have been adversely affected by the aforementioned actions, you can seek guidance by contacting:

• - Joseph E. Levi, Esq.

Email: [email protected]
Phone: (212) 363-7500

• - Address: 33 Whitehall Street, 27th Floor, New York, NY 10004

For further details and resources, visit the official website: Levi & Korsinsky

Don’t miss this critical opportunity to protect your investment in Ardent Health, Inc. The clock is ticking towards the lead plaintiff deadline, and your prompt action can make a difference.